Current evidence for topical azithromycin 1% ophthalmic solution in the treatment of blepharitis and blepharitis-associated ocular dryness

Int Ophthalmol Clin. 2011 Fall;51(4):43-52. doi: 10.1097/IIO.0b013e31822d6af1.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Azithromycin / administration & dosage*
  • Blepharitis / complications
  • Blepharitis / diagnosis
  • Blepharitis / drug therapy*
  • Diagnosis, Differential
  • Diagnostic Techniques, Ophthalmological
  • Dose-Response Relationship, Drug
  • Dry Eye Syndromes / diagnosis
  • Dry Eye Syndromes / drug therapy*
  • Dry Eye Syndromes / etiology
  • Eye Infections, Bacterial / complications
  • Eye Infections, Bacterial / diagnosis
  • Eye Infections, Bacterial / drug therapy*
  • Humans
  • Ophthalmic Solutions
  • Practice Guidelines as Topic
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Ophthalmic Solutions
  • Azithromycin